|
Epitope |
Antibody |
|
|
A
B
C
D
E
F
G
H
K
M O P
S
T
V |
|
ALK |
mAb ALK1 |
Herlev, DK
(Run 17)
■
Sundsvall,
SE (Run 17) |
|
mAb 5A4 |
Jyväskylä,
FI (Run 17) |
|
AMACR |
mAb 13H4 |
Anonymous (Run 26)
■
Hämeenlinna,
FI (Run 26)
■
Lier,
BE (Run 26)
■
Västerås, SE (Run 26) |
|
pAb CP200C |
Wien,
AT (Run 26) |
|
AMACR/PIN-cocktail |
cocktail |
Esbjerg, DK (Run 26)
■
Kassel, DE (Run 26)
■
Slagelse, DK (Run 26) |
|
ASMA |
mAb 1A4 |
Næstved, DK (Run 27)
■
Stockholm, SE (Run 27)
■
Berlin, DE
(Run 27) |
|
Bcl-2 |
mAb 100
|
Chemnitz, DE
(Run 28) |
|
mAb 100/D5 |
Granada, ES
(Run 28) |
|
mAb 124 |
Hillerød, DK
(Run 28) ■
Odense, DK
(Run 28) ■
Trollhättan,
SE (Run 28) |
|
mAb Bcl-2/100/D5 |
Oslo, NO
(Run 28) |
|
Bcl-6 |
mAb LN22 |
Odense, DK
(Run 28) ■
Jyväskylä, FI
(Run 28) |
|
mAb P1F6+PG-B6p |
Wien, AT
(Run 28) |
|
mAb PG-B6p |
Trondheim, NO
(Run 28) ■
Stockholm, SE
(Run 28) |
|
BSAP |
mAb 1EW |
Tampere, FI
(Run 28) |
|
mAb 24 |
Tilburg, NL
(Run 28) |
|
mAb DAK-Pax5 |
Herlev, DK
(Run 28) |
|
rmAb SP34 |
Seinäioki, FI
(Run 28) |
|
pAb RB-9406 |
Umeå, SE
(Run 28) |
|
Calretinin
(CR) |
mAb 5A5 |
Aalborg, DK
(Run 33) |
|
mAb Dak-Calret1 |
Vilnius, LT
(Run 33) |
|
mAb 5A5 |
Horn, NL
(Run 33) |
|
pAb 18-0211 |
Aliso Viejo, US
(Run 33) |
|
CA125 |
mAb M11 |
Kalmar, SE
(Run 29) ■
Leeuwarden, NL (Run 29)
■
Wiener Neustadt,
AT (Run 29) |
|
mAb OV185:1 |
Eindhoven, NL (Run
29)
■
Wien, AT (Run
29) |
|
CD3 |
mAb 2GV6 |
Malmö, SE
(Run 22) |
|
mAb F7.2.38 |
Sarajevo, BA
(Run 22) |
|
mAb LN10 |
Rotterdam, NL (Run 22) |
|
mAb PS1 |
Oulu, FI
(Run 22) |
|
mAb SP7 |
Skive, DK
(Run 22) |
|
pAb A0452 |
Bodø, NO
(Run 22) |
|
CD4 |
mAb 1F6 |
Stockholm, SE
(Run 29) |
|
mAb 4B12 |
Linköping, SE
(Run 29)
■
Rijeka, HR
(Run 29) |
|
mAb SP35 |
Aalborg, DK
(Run 29) |
|
CD5 |
mAb 4C7 |
Rotterdam,
NL (Run 34)
■
Vilnius, LT
(Run 34)
■
Bozen, IT
(Run 34) |
|
rmAb SP19 |
Aalborg, DK
(Run 34)
■
Bodø, NO
(Run 34) |
|
CD8 |
mAb 1A5 |
Irvine, USA
(Run 14) |
|
mAb 4B11 |
Seinäjoki, FI
(Run 14) |
|
mAb CD8/144B |
Västerås, SE
(Run 14) |
|
CD10 |
mAb 56C6 |
Leeuwarden, NL (Run 27)
■
Amsterdam, NL (Run 27)
■
Göteborg, Se (Run 27)
■ Anonymous
(Run 27)
|
|
CD14 |
mAb 7 |
Helsinki, FI (Run
11)
■
Næstved, DK (Run
11) |
|
CD15 |
mAb C3D-1 |
Linköping, SE
(Run 25) |
|
mAb Carb-3 |
Næstved, DK
(Run 25)
■
Barcelona, ES
(Run 25) |
|
mAb H198 |
Kuopio, FI
(Run 25) |
|
mAb MMA |
Roskilde, DK
(Run 25)
■
Anonymous
(Run 25) |
|
CD19 |
mAb LE-CD19 |
Aalborg, DK (Run 35)
■
Næstved, DK (Run 35)
■
Oulu, FI (Run 35) |
|
CD20 |
mAb 7D1 |
Stockholm, SE (Run 35) |
|
mAb L26 |
Dublin, IE (Run 35)
■
Iørenskog, NO (Run 35) |
|
rmAb EP7 |
Burlingame, US (Run 35) |
|
CD23 |
mAb 1B12 |
Næstved,
DK (Run 34)
■
Rotterdam,
NL (Run 34) |
|
rmAb SP23 |
Vicenza,
IT (Run 34)
■
Seinäjoki,
FI
(Run 34) |
|
mAb DAK-CD23 |
Holstebro,
DK (Run 34) |
|
CD30 |
mAb 1G12 |
Aliso Viejo, USA (Run
31) |
|
mAb
Ber-H2 |
Rotterdam,
NL (Run
31)
■
Norbyhagen,
N (Run
31) |
|
mAb
COND6/B5 |
Næstved,
DK (Run
31) |
|
mAb
JCM182 |
Wien,
AT (Run
31) |
|
CD31 |
mAb JC70A |
Herston, AU
(Run 32)
■
Oslo, N
(Run 32)
■
Skövde, SE
(Run 32) |
|
CD34 |
mAb My10 |
København,
DK (Run 30) |
|
QBEnd 10 |
Rijeka, HR
(Run 30) ■
Karlskrona, S (Run 30)
■
Tullamore, IRL (Run 30)
|
|
CD45 |
mAb 2B11+PD7/26 |
Trondheim, NO
(Run 15)
■
Sundsvall, SE
(Run 15) |
|
mAb RP2-18 |
Irvine, USA
(Run 15) |
|
mAb T29/33 |
Guangzhou, CHN
(Run 15) |
|
CD56 |
mAb 56C04 |
Hjørring, DK (Run 31) |
|
mAb 1B6 |
Oslo, N
(Run 31) |
|
mAb 123C3 |
Helsinki, FIN (Run 31) |
|
mAb 123C3.D5 |
Lillehammer, NO
(Run 31) |
|
mAb CD564 |
Wiener Neustadt, A
(Run 31) |
|
rmAb
MRQ-42 |
Odense,
DK (Run 31) |
|
CD68 |
mAb KP1 |
Utrecht,
NL (Run
31) |
|
mAb PG-M1 |
Kristianstad,
SE (Run
31) ■
Wien,
AT
(Run 31) |
|
mAb 514H12 |
PM,
NL (Run
31) |
|
CD79a |
mAb JCB117 |
Malmö, SE (Run
29)
■
Stockholm, SE (Run
29)
■
Sv. Nedjelja, HR (Run
29) |
|
rmAb SP18 |
Bonn, DE (Run
29)
■
Skien, NO
(Run 29) |
|
CD99 |
mAb 12E7 |
Vejle, DK (Run 28) ■
Seinäioki, FI (Run 28) |
|
mAb EPR3097Y |
Göteborg, SE (Run 28) ■
Aalborg, DK (Run 28) |
|
CD117 |
rmAb YR145 |
Aalborg, DK (Run 26)
■
Næstved, DK (Run 26) |
|
pAb A4502 |
Hillerød, DK (Run 26)
■
Kassel, DE (Run 26)
■
Lahti,
FI (Run 26) |
|
CD138 |
mAb B-A38 |
Dublin, IE (Run 36) |
|
mAb
B-B4 |
Seinäjoki, FI (Run 36) |
|
mAb MI15 |
Trondheim, NO (Run 36)
■
Stockholm, SV (Run 36) |
|
CD163 |
mAb 10D6 |
Halmstad,
SE (Run
31) |
|
mAb EDhu-1 |
København, DK (Run
31) |
|
rmAb MRQ-26 |
Aalborg,
DK (Run
31) |
|
CDX2 |
mAb DAK-CDX2 |
Blaricum, NL (Run
33) ■
Santiago de
Compostela, E (Run 33) |
|
rmAb EPR2764Y |
Holstebro, DK (Run 33)
■
Lund, S (Run 33)
■
Roskilde,
DK (Run 33) |
|
CEA |
mAb II-7 |
Helsingborg, SE (Run 27)
■
Rotterdam, NL (Run 27)
■
Santiago de Compostela, ES
(Run 27) |
|
mAb COL-1 |
Odense, DK ■
Drammen, NO |
|
Chromogranin
(CGA) |
mAb
LK2H10 + PHE5 |
Vancouver,
CA (Run
31) |
|
mAb
LK2H10 |
Blaricum,
NL (Run
31) |
|
pAb A0430 |
Danderyd, Stockholm,
SE (Run
31)
■
Reykjavik,
IS (Run
31) ■
Turku,
FIN (Run
31) |
|
Cyclin D1 |
rmAb SP4 |
Bodø, NO (Run 33)
■
Cork, IRL (Run 33)
■
Stockholm, SE (Run
33)
■
Täby, SE (Run 33) |
|
Cytokeratin,
high molecular weight |
mAb D5/16 B4 |
Herston, AU
(Run 32)
■
Odense, DK
(Run 32) |
|
mAb XM26 |
Aalborg, DK
(Run 32)
■
Herlev, DK
(Run 32)
■
Roskilde, DK
(Run 32) |
|
mAb XM26 & LL002 |
Chemnitz, D
(Run 32) |
|
Cytokeratin,
low molecular weight |
mAb 5D3 |
Slagelse, DK
(Run 33) |
|
mAb B22.1 & B23.1 |
Aalborg, DK
(Run 33) |
|
mAb C51 |
Saskatoon, CA
(Run 33) |
|
mAb CD10 |
Eindhoven, NL (Run 33)
■
Randers, DK (Run 33)
■
Trollhättan, SE
(Run 33) |
|
rmAb EP17 |
Odense C, DK
(Run 33) |
|
mAb TS1 |
Zaandam, NL
(Run 33) |
|
Cytokeratin, pan- |
mAb AE1/AE3 |
Hoorn, NL (Run 36)
■
Wien, AT (Run 36)
■
Tønsberg, NO (Run 36) |
|
mAb AE1/AE3 + 5D3 |
Roskilde, DK (Run 36) |
|
mAb KL1 |
Vejle, DK (Run 36) |
|
Cytokeratin 5 |
mAb 34BE12 |
Irvine, USA (Run
12)
■
Luleå, SE
(Run 12) |
|
mAb D5/16 B4 |
Seinäjoki, FI
(Run 12)
■
Svendborg, DK
(Run 12) |
|
mAb XM26 |
Kalmar, SE
(Run 12)
■
Stockholm, SE
(Run 12) |
|
Cytokeratin 7 |
mAb
OV/TL 12/30 |
Seinajoki, FI
(Run 25)
■
Firenze, IT
(Run 25)
■
Göteborg, SE (Run 25) |
|
Cytokeratin 19 |
mAb A53-B/A2.26 |
Wentworthville, AU
(Run 34) |
|
mAb B170 |
Stockholm, SE
(Run 34) |
|
mAb BA17 |
Sønderborg, DK
(Run 34) |
|
mAb Ks19.1 |
Linköping, SE
(Run 34) |
|
mAb RCK108 |
Stavanger, NO
(Run 34) |
|
Cytokeratin 20 |
mAb
Ks 20.8 |
Alkmaar, NL
(Run 35)
■ Cork,
IE
(Run 35)
■
Svendborg, DK
(Run 35) |
|
pAb E16444 |
Breda, NL
(Run 35)
■
Winschoten, NL
(Run 35) |
|
Desmin |
mAb D33 |
Oulu, FI
(Run 35)
■
Vilnius, LT
(Run 35) |
|
mAb DE-R-11 |
Rotterdam, NL
(Run 35)
■ Stockholm,
SE
(Run 35) |
|
pAb RB-9014 |
Willemstad, Curacao
(Run 35) |
|
E-cadherin (ECAD) |
mAb 36B5 |
Mistelbach,
AT (Run B5) |
|
mAb ECH-6 |
Århus, DK
(Run B5) |
|
mAb HECD-1 |
Göteborg,
SE (Run B5) |
|
mAb NCH-38 |
Haarlem, NL
(Run B5) |
|
Epithelial membrane antigen (EMA) |
mAb
E29 |
Vancouver, CA (Run
28) ■
Kristiansand,
NO (Run
28) ■
Eindhoven, NL (Run
28) |
|
mAb GP1.4 |
Luleå, SE (Run
28) |
|
mAb Mc5 |
Mistelbach, AT (Run
28) |
|
Epithelial cell adehesion molecule (Ep-CAM) |
mAb Ber EP4 |
Borås, S
(Run 32)
■
Linköping, S
(Run 32) |
|
mAb MOC-31 |
Lillehammer, N
(Run 32) |
|
mAb VU-1D9 |
Nijmegen, NL
(Run 32)
■
Sønderborg, DK
(Run 32) |
|
Estrogen receptor alpha
(ER) |
mAb 6F11 |
London, UK
(Run B13)
■ Oulu,
FI (Run B13) |
|
rmAb SP1 |
Mistelbach, AT
(Run B13)
■
Wiener
Neustadt, AT (Run B13) |
|
rmAb EP1 |
Mumbai, IN
(Run B13) |
|
Factor VIII related antigen
|
pAb 760-2642 |
Oslo, NO (Run
11) |
|
pAb A0082 |
Lindköping, SE
(Run 11)
■
Skövde, SE (Run
11)
■
Tampere, FI (Run
11) |
|
Glial fibrillary acidic protein |
mAb 6F2 |
Falun, SE
(Run 13)
■ Karlstad,
SE (Run 4) |
|
mAb GA5 |
Kaunas, LT
(Run 13) |
|
pAb Z0334 |
Anonymous
(Run 13)
■
Seinäjoki, FI (Run 13) |
|
Gross cystic disease fluid protein-15 |
mAb 23A3 |
Aliso Viejo, US (Run 36)
■
Zagreb, HR (Run 36) |
|
mAb D6 |
Amersfoort, NL (Run 36) |
|
rmAb EP1582Y |
Aalborg, DK (Run 36) |
|
Hepatocyte antigen |
mAb OCH1E5 |
Næstved, DK (Run36)
■
Malmö, SE (Run36)
■
Tilburg, NL (Run36) |
|
HER-2 IHC |
mAb CB11 |
Amersfoort,
NL
(Run B14) |
|
rmAb SP3 |
Rovaniemi,
FI
(Run B14) |
|
pAb A0485 |
Milano, IT
(Run B14) |
|
HercepTest™
(SK001) |
Vienna, AT
(Run B14) |
|
PATHWAY®
(rmAb 4B5) |
Stockholm,
SE
(Run B14) |
|
Oracle™
(mAb CB11) |
Badalona
(Barcelona), ES
(Run B14) |
|
HER-2 (Gastric) |
CONFIRM™
(rmAb 4B5) |
Turku, FIN (Run G2) |
|
pAb A0485 |
Leiden, NL (Run G2) |
|
HercepTest™
(K5207) |
Graz, AT (Run G2) |
|
Human chorionic
gonadotropin |
pAb A231 |
Esbjerg, DK (Run11)
■
Holstebro, DK (Run
11)
■
Lund, SE (Run
11) |
|
pAb NCL-HCGp |
Firenze, IT (Run
11) |
|
IgK |
pAb A0191 |
Jönköping,
SE (Run 23)
■
Odense, DK
(Run 23) |
|
IgL |
pAb A0193 |
Stockholm, SE
(Run 15)
■
Holstebro, DK
(Run 15) |
|
IgM |
pAb 0425 |
Eindhoven, NL
(Run 30) ■
Norbyhagen
Oslo, N (Run 30)
■
Turku, FIN (Run 30) |
|
Ki-67 |
|
mAb MIB1 |
Lund, SE (Run B13)
■
Saskatoon,
CA (Run B13) |
|
mAb MM1 |
Bozen, IT (Run B13) |
|
rmAb SP6 |
Holstebro, DK (Run B13)
■
Wien,
AT (Run B13) |
|
Mammaglobin |
mAb 304-1A5 |
Vejle, DK
(Run 25)
■
Göteborg, SE
(Run 25) |
|
rmAb 31A5 |
Skövde, SE
(Run 25) |
|
Melan A (MLA) |
mAb A103 |
Aalborg, DK (Run
31)
■
Portimão,
P (Run
31)
■
Bodø,
N (Run
31)
|
|
mAb
HMB45+M2-7C10+M2-9E3+T311 |
Vienna, A (Run
31)
■
Turku,
FIN
(Run 31) |
|
Mismatch repair protein
MLH1 |
mAb ES05 |
Leiden, NL
(Run 30) ■
Wien, A
(Run 30) |
|
mAb G168-15 |
Mistelbach, A
(Run 30) ■
Trondheim, N
(Run 30) |
|
Mismatch repair protein
MSH2 |
mAb 25D12 |
Trondheim, NO
(Run 22) |
|
mAb 27 |
Roskilde, DK
(Run 22) |
|
mAb FE11 |
Næstved, DK
(Run 22) |
|
MSH6 |
mAb 44 |
Concord, US
(Run 32) |
|
rmAb EP49 |
Næstved, DK
(Run 32)
■
Skive, DK
(Run 32) |
|
rmAb EPR3945 |
Esbjerg, DK
(Run 32) |
|
Melanosoma specific antigen (MSA / HMB45) |
mAb HMB45 (HIER) |
Firenze, IT
(Run 20)
■
Lillehammer, NO
(Run 20) |
|
mAb HMB45 (None) |
Berlin, DE
(Run 20)
■
Wien, AT
(Run 20) |
|
MUM1 |
mAb MUM1p |
Bozen, I
(Run 32)
■
Odense, DK
(Run 32)
■
Prague, CZ
(Run 32) |
|
Neurofilament proteisn (NFP) |
mAb 2F11 |
Jönköping,
SE
(Run 18)
■
Sundsvall,
SE
(Run 18) |
|
mAb NFP7, DA2, RmdO20.11 |
Firenze, IT
(Run 18)
■
Oslo, NO
(Run 18) |
|
OCT3/4 |
mAb C-10 |
Lahti, FI (Run 35)
■
Vejle, DK (Run 35)
■
Vienna, AT (Run 35) |
|
|
mAb MRQ-10 |
Dublin, IE (Run 35)
■
Hjørring, DK (Run 35) |
|
|
mAb N1NK |
Vicenza, IT (Run 35) |
|
p16ink4a |
mAb E6H4 |
Randers,
DK (Run 26)
■
Stavanger, NO (Run 26) |
|
mAb G175-405 |
Seinajoki,
FI (Run 26) |
|
mAb JC8 |
Hvidovre, DK (Run 26) |
|
p53 |
mAb BP53-12 |
Barcelona, ES
(Run 20) |
|
mAb DO-1 |
Kassel, DE
(Run 20) |
|
mAb DO-7 |
Örebro, SE
(Run 20)
■
Sundsvall, SE
(Run 20) |
|
mAb DO-7+BP53-12 |
Wien, AT
(Run 20) |
|
p63 |
mAb 4A4 |
Den
Haag, NL (Run B8) ■
Anonymous (Run B8) |
|
mAb 4A4 + Y4A3 |
Lahti,
FI (Run B8) |
|
mAb BC4A4 |
Bridgewater,
CA (Run B8) |
|
PAX8 |
mAb BC12 |
Concord, US
(Run 34) |
|
pAb 363-15 |
Aalborg,
DK (Run 34) |
|
pAb CP379 |
Odense, DK
(Run 34) ■
Stavanger,
NO (Run 34) |
|
Prostatic acid phosphatase (PAP) |
mAb PASE/4LJ |
Kristiansand, NO
(Run 12)
■
Seinäjoki, FI (Run
12) |
|
pAb A0627 |
Helsingborg, SE
(Run 12)
■
Holstebro, DK
(Run 12) |
|
Prostein (P501s) |
mAb 10E3 |
Svendborg, DK
(Run 27)
|
|
Placental alkaline phosphatase
(PLAP) |
mAb 8A9 |
Hoorn, NL (Run 35)
■
Malmö, SE (Run 35)
■
Zagreb, HR (Run 35) |
|
mAb NB10 |
Wentworthville, AU (Run 35) |
|
mAb PL8-F6 |
Tampere, FI (Run 35) |
|
rmAb SP15 |
Trondheim, NO (Run 35) |
|
Podoplanin |
mAb D2-40 |
Wien, AT (Run 36)
■
Borås, SE (Run 36)
■
Oslo, NO (Run 36) |
|
Progesterone (PR) |
mAb 16 |
Charlottetown, CA (Run B14)
■
Oslo, NO (Run B14) |
|
mAb PgR 636 |
Romford, GB (Run B14) |
|
rmAb SP2 |
Évora, PT (Run B14) |
|
rmAb Y85 |
Taipei, TW (Run B14) |
|
Prostate
specific antigen (PSA) |
mAb 35H9 |
Mistelbach,
AT
(Run 27)
|
|
mAb ER-PR8 |
Lillehammer, NO
(Run 27)
|
|
mAb ER-PR8+PA05 |
Ålesund,
NO
(Run 27)
|
|
pAb 760-2506 |
Anonymous
(Run 27)
|
|
pAb A0562 |
Århus, DK
(Run 27)
■
Blaricum,
NL
(Run 27)
|
|
pAb IR514 |
Örebro,
SE
(Run 27)
|
|
S-100 protein |
pAb Z0311 (HIER) |
Delft, NL
(Run 34) ■
Guetersloh, DE (Run 34) ■
Tullamore,
IE (Run 34) |
|
Smooth muscle myosin heavy chain (SMH) |
mAb S131 |
Stockholm, SE (Run B8) |
|
mAb SMMS-1 |
Odense, DK (Run B8) ■
Anonymous (Run B8) |
|
Synaptophysin (SYP) |
mAb 27G12 |
Hämeenlinna, FI (Run
29)
■
Helsingborg, SE (Run
29)
■
Kristiansand,
NO (Run 29) |
|
mAb Snp88 |
Holstebro, DK (Run
29)
■
Leeuwarden, NL
(Run 29) |
|
rmAb SP11 |
Rotterdam, NL (Run
29)
■
Seinäjoki,
FI (Run 29) |
|
TdT |
mAb SEN28 |
Bergen, NO
(Run 18)
■
Sundsvall,
SE
(Run 18) |
|
pAb A3524 |
Herlev, DK
(Run 18)
■
Umeå, SE
(Run 18) |
|
pAb 004 |
Leiden, NL
(Run 18) |
|
Thyroid
transcription factor-1 TTF1) |
mAb SPT24 |
Graz, A (Run 33)
■
Hillerød, DK
(Run 33)
■
Vilnius, LT (Run 33) |
|
Vimentin |
mAb 3B4 |
Kristianstad, S
(Run 30) |
|
mAb V9 |
PM, NL
(Run 30) ■
Romford, UK
(Run 30) |
|
rmAb SP20 |
Prague, CZ
(Run 30) |
|
Wilms' tumour-1 (WT1) |
mAb 6F-H2 |
Aalborg, DK (Run 28) ■
Heerlen, NL
(Run 28) |
|
mAb WT49 |
PM, NL (Run 28) ■
Svendborg, DK
(Run 28) |
|